Research Solutions Amends 8-K Filing for Financial Statements
Ticker: RSSS · Form: 8-K/A · Filed: Feb 7, 2024 · CIK: 1386301
| Field | Detail |
|---|---|
| Company | Research Solutions, Inc. (RSSS) |
| Form Type | 8-K/A |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: amendment, financial-statements, regulatory-filing
TL;DR
**Research Solutions just updated an old filing, likely fixing minor details on financials.**
AI Summary
Research Solutions, Inc. (RSSS) filed an 8-K/A on February 7, 2024, amending a previous report from December 1, 2023. This amendment clarifies or updates information related to financial statements and exhibits, specifically noting the company's common stock, $0.001 par value, is traded on The Nasdaq Capital Market under the symbol RSSS. This matters to investors as it ensures the public record is accurate regarding the company's financial disclosures and trading information, providing transparency for current and potential shareholders.
Why It Matters
This amendment ensures that the public record for Research Solutions, Inc. is accurate and up-to-date regarding its financial statements and exhibits, which is crucial for investor confidence and regulatory compliance.
Risk Assessment
Risk Level: low — An 8-K/A filing typically corrects or amends previous disclosures, which is a standard procedure and generally does not indicate new, significant risks unless the amendment itself reveals a major issue.
Analyst Insight
Investors should review the original 8-K from December 1, 2023, and this amendment to understand the specific changes made to the financial statements and exhibits, ensuring all public disclosures are consistent and accurate.
Key Numbers
- $0.001 — par value per share (This is the stated par value for Research Solutions, Inc.'s common stock.)
Key Players & Entities
- Research Solutions, Inc. (company) — the registrant filing the 8-K/A
- The Nasdaq Capital Market (company) — the exchange where RSSS common stock is registered
- RSSS (company) — the trading symbol for Research Solutions, Inc.
- $0.001 (dollar_amount) — par value of common stock
- December 1, 2023 (date) — date of the earliest event reported in the original 8-K
- February 7, 2024 (date) — date the 8-K/A was filed
FAQ
What is the purpose of this 8-K/A filing by Research Solutions, Inc.?
This 8-K/A (Amendment No. 1) is filed by Research Solutions, Inc. to amend a previous Current Report on Form 8-K, specifically concerning 'Financial Statements and Exhibits' as indicated by the 'ITEM INFORMATION' and 'FORM 8-K/A (Amendment No. 1)' sections.
When was the original event reported that this 8-K/A is amending?
The original event reported, which this 8-K/A amends, occurred on December 1, 2023, as stated under 'Date of Report: (Date of earliest event reported) December 1, 2023'.
What is the trading symbol and exchange for Research Solutions, Inc.'s common stock?
Research Solutions, Inc.'s common stock, with a $0.001 par value, trades under the symbol RSSS on The Nasdaq Capital Market, as detailed in the 'Securities registered pursuant to Section 12(b) of the Act' table.
What is the state of incorporation for Research Solutions, Inc.?
Research Solutions, Inc. is incorporated in Nevada, as indicated by 'Nevada (State or other Jurisdiction of Incorporation)' in the filing.
What was the former name of Research Solutions, Inc. and when did the name change occur?
The former conformed name of Research Solutions, Inc. was Derycz Scientific Inc, and the date of the name change was January 12, 2007, according to the 'FORMER COMPANY' section of the filing.
Filing Stats: 803 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-02-07 16:15:40
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value RSSS The Nasdaq Capital Mar
Filing Documents
- tm245389d1_8ka.htm (8-K/A) — 27KB
- tm245389d1_ex23-1.htm (EX-23.1) — 2KB
- tm245389d1_ex99-1.htm (EX-99.1) — 127KB
- tm245389d1_ex99-2.htm (EX-99.2) — 108KB
- tm245389d1_ex99-3.htm (EX-99.3) — 119KB
- 0001104659-24-011617.txt ( ) — 591KB
- rsss-20231201.xsd (EX-101.SCH) — 3KB
- rsss-20231201_lab.xml (EX-101.LAB) — 33KB
- rsss-20231201_pre.xml (EX-101.PRE) — 22KB
- tm245389d1_8ka_htm.xml (XML) — 3KB
01. Financial Statements
Item 9.01. Financial Statements and Exhibits. (a) Financial Statements of Businesses Acquired. The audited balance sheet of Scite as of June 30, 2023, and the related statement of operations, stockholders' equity and cash flows for the fiscal years ended June 30, 2023, along with the accompanying notes and the independent auditor's report related thereto, are included as Exhibit 99.1 to this report and incorporated by reference herein. The unaudited interim condensed balance sheets of Scite as of September 30, 2023 and June 30, 2023 and the related statement of operations, stockholders' equity and cash flows for the three months ended September 30, 2023, along with the accompanying notes, are included as Exhibit 99.2 to this report and incorporated by reference herein. (b) Pro Forma Financial Information. The Registrant's unaudited pro forma condensed combined balance sheet as of September 30, 2023 and unaudited pro forma condensed combined statement of operations for the three months ended September 30, 2023 and the year ended June 30, 2023, along with the accompanying notes, giving effect to the Merger, are included as Exhibit 99.3 to this report and incorporated by reference herein. (d) Exhibits. Exhibit No. Description 23.1 Consent of Independent Registered Public Accounting Firm. 99.1 Audited Financial Statements of Scite as of June 30, 2023 and for the fiscal year ended June 30, 2023. 99.2 Unaudited Financial Statements of Scite as of September 30, 2023 and for the three months ended September 30, 2023. 99.3 Unaudited Pro Forma Condensed Combined Financial Information of Research Solutions, Inc. 104 Cover Page Interactive Data File (embedded as Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RESEARCH SOLUTIONS, INC. Date: February 7, 2024 By: /s/ William Nurthen Wi